![Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder](https://neurologyindia.com/articles/2020/68/5/images/ni_2020_68_5_1106_294831_f3.jpg)
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder
![Anti-MOG autoantibody-associated schizophreniform psychosis | Acta Neuropsychiatrica | Cambridge Core Anti-MOG autoantibody-associated schizophreniform psychosis | Acta Neuropsychiatrica | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20220209113020047-0373:S0924270821000296:S0924270821000296_fig1.png?pub-status=live)
Anti-MOG autoantibody-associated schizophreniform psychosis | Acta Neuropsychiatrica | Cambridge Core
![Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders? Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?](https://www.frontiersin.org/files/Articles/421928/fimmu-09-02753-HTML/image_m/fimmu-09-02753-g001.jpg)
Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
![Defining distinct features of anti-MOG antibody associated central nervous system demyelination - Martin S. Weber, Tobias Derfuss, Imke Metz, Wolfgang Brück, 2018 Defining distinct features of anti-MOG antibody associated central nervous system demyelination - Martin S. Weber, Tobias Derfuss, Imke Metz, Wolfgang Brück, 2018](https://journals.sagepub.com/cms/10.1177/1756286418762083/asset/images/large/10.1177_1756286418762083-fig1.jpeg)
Defining distinct features of anti-MOG antibody associated central nervous system demyelination - Martin S. Weber, Tobias Derfuss, Imke Metz, Wolfgang Brück, 2018
![Recent developments in MOG-IgG associated neurological disorders - Harald Hegen, Markus Reindl, 2020 Recent developments in MOG-IgG associated neurological disorders - Harald Hegen, Markus Reindl, 2020](https://journals.sagepub.com/cms/10.1177/1756286420945135/asset/images/large/10.1177_1756286420945135-fig3.jpeg)
Recent developments in MOG-IgG associated neurological disorders - Harald Hegen, Markus Reindl, 2020
![Recent developments in MOG-IgG associated neurological disorders - Harald Hegen, Markus Reindl, 2020 Recent developments in MOG-IgG associated neurological disorders - Harald Hegen, Markus Reindl, 2020](https://journals.sagepub.com/cms/10.1177/1756286420945135/asset/images/large/10.1177_1756286420945135-fig2.jpeg)
Recent developments in MOG-IgG associated neurological disorders - Harald Hegen, Markus Reindl, 2020
![IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD](https://www.mdpi.com/ijms/ijms-22-07925/article_deploy/html/images/ijms-22-07925-g001.png)
IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
![MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder - ScienceDirect MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211034818302360-gr1.jpg)
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder - ScienceDirect
![Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology](https://pn.bmj.com/content/practneurol/19/3/187/F1.large.jpg)
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
![IJMS | Free Full-Text | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management IJMS | Free Full-Text | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management](https://www.mdpi.com/ijms/ijms-22-00100/article_deploy/html/images/ijms-22-00100-g003.png)
IJMS | Free Full-Text | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management
![Table 1 from Defining distinct features of anti-MOG antibody associated central nervous system demyelination | Semantic Scholar Table 1 from Defining distinct features of anti-MOG antibody associated central nervous system demyelination | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/602411f8e428be6137e02167a138ed2b523b9c16/5-Table1-1.png)
Table 1 from Defining distinct features of anti-MOG antibody associated central nervous system demyelination | Semantic Scholar
![MOG Antibody–Associated Disease and Thymic Hyperplasia | Neurology Neuroimmunology & Neuroinflammation MOG Antibody–Associated Disease and Thymic Hyperplasia | Neurology Neuroimmunology & Neuroinflammation](https://nn.neurology.org/content/nnn/10/2/e200077/F3.large.jpg)